Lassa fever–induced sensorineural hearing loss: A neglected public health and social burden

PLoS Neglected Tropical Diseases

Volumn 12, Issue 2, 2018, Pages

  Mateer, Elizabeth J ^a   Huang, Cheng ^a   Shehu, Nathan Y ^b   Paessler, Slobodan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF JOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ANTIVIRAL THERAPY; BIBLIOGRAPHIC DATABASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LASSA FEVER; MORTALITY RATE; NONHUMAN; PERCEPTION DEAFNESS; PREVALENCE; QUALITY OF LIFE; REVIEW; SOCIOECONOMICS; VIRUS DETECTION; AFRICA; ANIMAL; COMPLICATION; COST OF ILLNESS; DISEASE MODEL; IMMUNOLOGY; LASSA VIRUS; MOUSE; NIGERIA; PATHOGENICITY; PUBLIC HEALTH; VIROLOGY;

AFRICA, WESTERN; ANIMALS; COST OF ILLNESS; DISEASE MODELS, ANIMAL; HEARING LOSS, SENSORINEURAL; HUMANS; LASSA FEVER; LASSA VIRUS; MICE; NIGERIA; PUBLIC HEALTH; QUALITY OF LIFE; SOCIOECONOMIC FACTORS;

EID: 85044251927     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0006187     Document Type: Review

References (56)

1. Ogbu O, Ajuluchukwu E, Uneke CJ, Lassa fever in West African sub-region: an overview. J Vector Borne Dis. 2007;44(1):1–11. 17378212.
2. Murphy FA, Arenavirus taxonomy: a review. Bull World Health Organ. 1975;52(4–6):389–91. 182395; PubMed Central PMCID: PMCPMC2366659.
3. McLay L, Liang Y, Ly H, Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. J Gen Virol. 2014;95(Pt 1):1–15. Epub 2013/09/25. doi: 10.1099/vir.0.057000-0 24068704; PubMed Central PMCID: PMCPMC4093776.
4. Yun NE, Walker DH, Pathogenesis of Lassa fever. Viruses. 2012;4(10):2031–48. Epub 2012/10/09. doi: 10.3390/v4102031 23202452; PubMed Central PMCID: PMCPMC3497040.
5. Buchmeier MJ, de la Torre J-C, Peters CJ, Knipe DM, Howley PM,,Arenaviridae: the viruses and their replication. In: Fields Virology. 2: Lippincott Williams & Wilkins; 2006.
6. Cummins D, McCormick JB, Bennett D, Samba JA, Farrar B, Machin SJ, et al. Acute sensorineural deafness in Lassa fever. JAMA. 1990;264(16):2093–6. 2214077.
7. Olusanya BO, Neumann KJ, Saunders JE, The global burden of disabling hearing impairment: a call to action. Bull World Health Organ. 2014;92(5):367–73. Epub 2014/02/18. doi: 10.2471/BLT.13.128728 24839326; PubMed Central PMCID: PMCPMC4007124.
8. Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC, Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif. 2011;15(3):91–105. Epub 2011/05/22. doi: 10.1177/1084713811408349 21606048; PubMed Central PMCID: PMCPMC4040829.
9. McPherson B, Brouillette R, Audiology in developing countries. New York: Nova Science Publishers, Inc.; 2008. 254 p.
10. Cohen BE, Durstenfeld A, Roehm PC, Viral causes of hearing loss: a review for hearing health professionals. Trends Hear. 2014;18. Epub 2014/07/29. doi: 10.1177/2331216514541361 25080364; PubMed Central PMCID: PMCPMC4222184.
11. Mylne AQ, Pigott DM, Longbottom J, Shearer F, Duda KA, Messina JP, et al. Mapping the zoonotic niche of Lassa fever in Africa. Trans R Soc Trop Med Hyg. 2015;109(8):483–92. Epub 2015/06/17. doi: 10.1093/trstmh/trv047 26085474; PubMed Central PMCID: PMCPMC4501400.
12. Lassa fever. Br Med J. 1972;4(5835):253–4. 5083882; PubMed Central PMCID: PMCPMC1788780.
13. Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A, Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science. 1974;185(4147):263–5. 4833828.
14. Ter Meulen J, Lukashevich I, Sidibe K, Inapogui A, Marx M, Dorlemann A, et al. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg. 1996;55(6):661–6. 9025695.
15. (WHO) WHO. Lassa Fever: World Health Organization (WHO); 2016. Available from: http://www.who.int/mediacentre/factsheets/fs179/en/. Accessed on 17 May 2017.
16. Richmond JK, Baglole DJ, Lassa fever: epidemiology, clinical features, and social consequences. BMJ. 2003;327(7426):1271–5. doi: 10.1136/bmj.327.7426.1271 14644972; PubMed Central PMCID: PMCPMC286250.
17. Sogoba N, Feldmann H, Safronetz D, Lassa fever in West Africa: evidence for an expanded region of endemicity. Zoonoses Public Health. 2012;59Suppl 2:43–7. doi: 10.1111/j.1863-2378.2012.01469.x 22958249.
18. Akoua-Koffi C, Ter Meulen J, Legros D, Akran V, Aïdara M, Nahounou N, et al. [Detection of anti-Lassa antibodies in the Western Forest area of the Ivory Coast]. Med Trop (Mars). 2006;66(5):465–8. 17201291.
19. Price ME, Fisher-Hoch SP, Craven RB, McCormick JB, A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ. 1988;297(6648):584–7. 3139220; PubMed Central PMCID: PMCPMC1834487.
20. Härkönen K, Kivekäs I, Rautiainen M, Kotti V, Vasama JP, Quality of life and hearing eight years after sudden sensorineural hearing loss. Laryngoscope. 2017;127(4):927–31. Epub 2016/06/21. doi: 10.1002/lary.26133 27328455.
21. Adobamen PROC, The pattern of hearing loss as seen at the University of Benin Teaching Hospital, Benin City, Nigeria. Gomal Journal of Medical Sciences. 2013;11(2):133–7.
22. Seely DR, Gloyd SS, Wright AD, Norton SJ, Hearing loss prevalence and risk factors among Sierra Leonean children. Arch Otolaryngol Head Neck Surg. 1995;121(8):853–8. 7619409.
23. Dunmade AD, Segun-Busari S, Olajide TG, Ologe FE, Profound bilateral sensorineural hearing loss in Nigerian children: any shift in etiology?J Deaf Stud Deaf Educ. 2007;12(1):112–8. Epub 2006/09/06. doi: 10.1093/deafed/enl019 16956969.
24. Prescott JB, Marzi A, Safronetz D, Robertson SJ, Feldmann H, Best SM, Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol. 2017;17(3):195–207. Epub 2017/01/23. doi: 10.1038/nri.2016.138 28111475.
25. Paessler S, Walker DH, Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol. 2013;8:411–40. Epub 2012/11/01. doi: 10.1146/annurev-pathol-020712-164041 23121052.
26. Tam RC, Lau JY, Hong Z, Mechanisms of action of ribavirin in antiviral therapies. Antivir Chem Chemother. 2001;12(5):261–72. doi: 10.1177/095632020101200501 11900345.
27. Rusnack J, Experience with ribavirin for treatment and postexposure prophylaxis of hemorrhagic fever viruses: Crimean Congo hemorrhagic fever, Lassa fever, and Hantaviruses. Applied Biosafety. 2011;16(2):20.
28. White HA, Lassa fever. A study of 23 hospital cases. Trans R Soc Trop Med Hyg. 1972;66(3):390–401. 5046379.
29. McCormick JB, King IJ, Webb PA, Johnson KM, O'Sullivan R, Smith ES, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987;155(3):445–55. 3805772.
30. Mertens PE, Patton R, Baum JJ, Monath TP, Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg. 1973;22(6):780–4. 4745237.
31. Henderson BE, Gary GW, Kissling RE, Frame JD, Carey DE, Lassa fever. Virological and serological studies. Trans R Soc Trop Med Hyg. 1972;66(3):409–16. 4625715.
32. Macher AM, Wolfe MS, Historical Lassa fever reports and 30-year clinical update. Emerg Infect Dis. 2006;12(5):835–7. doi: 10.3201/eid1205.050052 16704848; PubMed Central PMCID: PMCPMC3374442.
33. Okokhere PO, Ibekwe TS, Akpede GO, Sensorineural hearing loss in Lassa fever: two case reports. J Med Case Rep. 2009;3:36. Epub 2009/01/29. doi: 10.1186/1752-1947-3-36 19178735; PubMed Central PMCID: PMCPMC2642856.
34. Grahn A, Bråve A, Lagging M, Dotevall L, Ekqvist D, Hammarström H, et al. Imported case of Lassa fever in Sweden with encephalopathy and sensorineural hearing deficit. Open Forum Infect Dis. 2016;3(4):ofw198. Epub 2016/09/20. doi: 10.1093/ofid/ofw198 27975074; PubMed Central PMCID: PMCPMC5152670.
35. Okano T, Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss. Front Pharmacol. 2014;5:205. Epub 2014/09/02. doi: 10.3389/fphar.2014.00205 25228882; PubMed Central PMCID: PMCPMC4151383.
36. Ibekwe TS, Okokhere PO, Asogun D, Blackie FF, Nwegbu MM, Wahab KW, et al. Early-onset sensorineural hearing loss in Lassa fever. Eur Arch Otorhinolaryngol. 2011;268(2):197–201. Epub 2010/09/01. doi: 10.1007/s00405-010-1370-4 20809263.
37. Yun NE, Ronca S, Tamura A, Koma T, Seregin AV, Dineley KT, et al. Animal model of sensorineural hearing loss associated with Lassa virus infection. J Virol. 2015;90(6):2920–7. Epub 2015/12/30. doi: 10.1128/JVI.02948-15 26719273; PubMed Central PMCID: PMCPMC4810655.
38. Yun NE, Seregin AV, Walker DH, Popov VL, Walker AG, Smith JN, et al. Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol. 2013;87(19):10908–11. Epub 2013/07/31. doi: 10.1128/JVI.01433-13 23903830; PubMed Central PMCID: PMCPMC3807383.
39. Yun NE, Poussard AL, Seregin AV, Walker AG, Smith JK, Aronson JF, et al. Functional interferon system is required for clearance of lassa virus. J Virol. 2012;86(6):3389–92. Epub 2012/01/11. doi: 10.1128/JVI.06284-11 22238311; PubMed Central PMCID: PMCPMC3302329.
40. Liao BS, Byl FM, Adour KK, Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause. Otolaryngol Head Neck Surg. 1992;106(3):226–9. doi: 10.1177/019459989210600303 1589210.
41. Crowson MG, Hertzano R, Tucci DL, Emerging therapies for sensorineural hearing loss. Otol Neurotol. 2017. Epub 2017/04/05. doi: 10.1097/MAO.0000000000001427 28383465.
42. Günther S, Weisner B, Roth A, Grewing T, Asper M, Drosten C, et al. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis. 2001;184(3):345–9. Epub 2001/07/03. doi: 10.1086/322033 11443561.
43. Oestereich L, Lüdtke A, Ruibal P, Pallasch E, Kerber R, Rieger T, et al. Chimeric mice with competent hematopoietic immunity reproduce key features of severe Lassa fever. PLoS Pathog. 2016;12(5):e1005656. Epub 2016/05/18. doi: 10.1371/journal.ppat.1005656 27191716; PubMed Central PMCID: PMCPMC4871546.
44. McElroy AK, Akondy RS, Harmon JR, Ellebedy AH, Cannon D, Klena JD, et al. A case of human Lassa virus infection with robust acute T-cell activation and long-term virus-specific T-cell responses. Journal of Infectious Diseases. 2017. https://doi.org/10.1093/infdis/jix201.
45. Chen HC, Chung CH, Wang CH, Lin JC, Chang WK, Lin FH, et al. Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection. PLoS ONE. 2017;12(4):e0175266. Epub 2017/04/06. doi: 10.1371/journal.pone.0175266 28384326; PubMed Central PMCID: PMCPMC5383281.
46. Schachtele SJ, Mutnal MB, Schleiss MR, Lokensgard JR, Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol. 2011;17(3):201–11. Epub 2011/03/18. doi: 10.1007/s13365-011-0024-7 21416394; PubMed Central PMCID: PMCPMC3098308.
47. Bradford RD, Yoo YG, Golemac M, Pugel EP, Jonjic S, Britt WJ, Murine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neurons. PLoS Pathog. 2015;11(4):e1004774. Epub 2015/04/13. doi: 10.1371/journal.ppat.1004774 25875183; PubMed Central PMCID: PMCPMC4395355.
48. Carraro M, Almishaal A, Hillas E, Firpo M, Park A, Harrison RV, Cytomegalovirus (CMV) infection causes degeneration of cochlear vasculature and hearing loss in a mouse model. J Assoc Res Otolaryngol. 2017;18(2):263–73. Epub 2016/12/19. doi: 10.1007/s10162-016-0606-4 27995350; PubMed Central PMCID: PMCPMC5352614.
49. So H, Kim H, Lee JH, Park C, Kim Y, Kim E, et al. Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. J Assoc Res Otolaryngol. 2007;8(3):338–55. Epub 2007/05/22. doi: 10.1007/s10162-007-0084-9 17516123; PubMed Central PMCID: PMCPMC2538433.
50. Fujioka M, Kanzaki S, Okano HJ, Masuda M, Ogawa K, Okano H, Proinflammatory cytokines expression in noise-induced damaged cochlea. J Neurosci Res. 2006;83(4):575–83. doi: 10.1002/jnr.20764 16429448.
51. Solbrig M, McCormick J, Lassa fever: central nervous system manifestations. Journal of Tropical and Geographical Neurology. 1991;1:23–30.
52. Solbrig MV, Salvato MS, Lassa virus and central nervous system diseases. In: The Arenaviridae. New York: Plenum Press; 1993. p. 325–9.
53. Cummins D, Bennett D, Fisher-Hoch SP, Farrar B, Machin SJ, McCormick JB, Lassa fever encephalopathy: clinical and laboratory findings. J Trop Med Hyg. 1992;95(3):197–201. 1597876.
54. Zweighaft RM, Fraser DW, Hattwick MA, Winkler WG, Jordan WC, Alter M, et al. Lassa fever: response to an imported case. N Engl J Med. 1977;297(15):803–7. doi: 10.1056/NEJM197710132971504. 895819
55. Maiztegui JI, Fernandez NJ, de Damilano AJ, Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet. 1979;2(8154):1216–7. 92624.
56. Bonthius DJ, Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult. Semin Pediatr Neurol. 2012;19(3):89–95. doi: 10.1016/j.spen.2012.02.002 22889536; PubMed Central PMCID: PMCPMC4256959.